このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Improving Maternal and Neonatal Care-seeking Through a Video-informed Training Session During the Third Trimester of Pregnancy (Taabo T3)

2026年9月14日 更新者:Swiss Tropical & Public Health Institute

Improving Maternal and Neonatal Care-Seeking Through a Video-Informed Training Session During the Third Trimester of Pregnancy

This study is a randomized controlled trial evaluating the impact of a video-informed training session on maternal and newborn health care seeking in rural Côte d'Ivoire.

調査の概要

詳細な説明

In Taabo, Côte d'Ivoire, many women do not receive recommended care during the third trimester of pregnancy or the early postpartum period, contributing to adverse maternal and neonatal health outcomes. In this individual-level open-label randomized controlled trial, we will evaluate the impact of an information and planning intervention on timely care-seeking during the third trimester of pregnancy and the early postpartum period. The study will enroll 800 women who are currently in the third trimester of pregnancy and randomize them to one of two groups: (1) control, or (2) information video and planning session for the pregnant women and her partner. A baseline survey will be performed at the time of enrollment, and outcomes will be evaluated using an endline survey 6-8 weeks after the end of pregnancy. The main outcome of the study is the number of health care contacts that women have between enrollment in the study and 6 weeks postpartum.

研究の種類

介入

入学 (推定)

800

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Taabo、コートジボワール
        • Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子
  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria for Pregnant Women:

  • Currently pregnant
  • Aged 15 years or older
  • Live in the area served by the Taabo Health & Demographic Surveillance System
  • Estimated gestational age between 6 completed months of pregnancy and 8 completed months of pregnancy

Inclusion Criteria for Male Partners:

  • Aged 15 or older
  • Married to or currently the main romantic partner of a woman who is enrolled in the study

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:ヘルスサービス研究
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
介入なし:Control group
This group will not receive any intervention.
実験的:Information Video and Planning Session group
This group will receive the study intervention, including an information video and planning session for the pregnant woman and her partner.
The study intervention is a video-informed information and planning session for health care during the third trimester, childbirth, and the first six weeks postpartum. In this intervention, a member of the study team will show information videos to pregnant women and her partner, summarizing key recommendations for health and health care seeking during the third trimester of pregnancy and the first six weeks following childbirth. After showing the videos, the study team member will guide the pregnant woman and her partner in a short discussion about planning for care-seeking during the third trimester and early postpartum period. This discussion will include quizzing on the content of the information videos and discussions of care-seeking plans together with the couple.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Number of health care contacts as reported by women during endline survey
時間枠:From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
Number of health care contacts that women have between enrollment in the study and 6 weeks postpartum, including antenatal care visits, childbirth, and postpartum care visits
From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)

二次結果の測定

結果測定
メジャーの説明
時間枠
Number of antenatal care visits as reported by women during endline survey
時間枠:Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
Number of antenatal care visits
Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
Facility-based childbirth as reported by women during endline survey
時間枠:Measured 6-8 weeks after the end of pregnancy
Proportion of women who gave birth in a health facility
Measured 6-8 weeks after the end of pregnancy
Number of postpartum visits as reported by women during endline survey
時間枠:From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
Number of postpartum care visits between the end of pregnancy and 6 weeks postpartum
From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
Fetal movement counting as reported by women during endline surveys
時間枠:Measured 6-8 weeks after the end of pregnancy
The proportion of pregnant women who report counting fetal movements at least once during the final month of their pregnancy
Measured 6-8 weeks after the end of pregnancy
Perinatal mortality as reported by women during endline surveys
時間枠:Measured 6-8 weeks after end of pregnancy
The proportion of women who experience a stillbirth or neonatal death in the first seven days of life (perinatal mortality)
Measured 6-8 weeks after end of pregnancy
Neonatal mortality as reported by women during endline surveys
時間枠:Measured 6-8 weeks after end of pregnancy
The proportion of women whose child dies in the first 28 days of life
Measured 6-8 weeks after end of pregnancy
Average care-seeking knowledge scores among pregnant women and their partners
時間枠:Measured 6-8 weeks after the end of pregnancy

Average scores (among pregnant women and their partners) on assessments of knowledge of care-seeking recommendations during the third trimester and the early postpartum period, as measured using five questions during endline surveys with pregnant women and their partners.

We create a Care-Seeking Knowledge Scale as follows: Participants receive 1 point if they respond with 3 or more when asked how many postpartum visits women should have during the first 6 weeks after childbirth; 1 point if they correctly name at least 3 danger signs for women during pregnancy; 1 point if they correctly name at least 3 danger signs for women during the first six weeks after childbirth; and 1 point if they correctly name at least 3 danger signs for newborns. Scores range from 0 to 4 with higher scores representing greater knowledge.

Measured 6-8 weeks after the end of pregnancy

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年9月1日

一次修了 (推定)

2027年5月1日

研究の完了 (推定)

2027年5月1日

試験登録日

最初に提出

2026年9月8日

QC基準を満たした最初の提出物

2026年9月8日

最初の投稿 (実際)

2026年9月14日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月17日

QC基準を満たした最後の更新が送信されました

2026年9月14日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

De-identified data files and analytic code will be posted on public repositories at the time of publication of results.

IPD 共有時間枠

We plan to share IPD and supporting information at the time of publication.

IPD 共有アクセス基準

IPD and supporting information will be made available on public repositories.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する